ArticleFrontiers in oncology2023

Case report: Ruxolitinib plus dexamethasone as first-line therapy in haemophagocytic lymphohistiocytosis.

Lin Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.